Personal information

Activities

Works (12)

Treatments and Outcomes in Neuroendocrine Patients Treated with Long-Acting Somatostatin Analogues: An Italian Real-World Propensity Score-Matched Cohort Study

Biomedicines
2025-02-19 | Journal article
Contributors: Nicoletta Ranallo; Andrea Roncadori; Nicola Gentili; William Balzi; Mattia Altini; Virginia Ghini; Roberta Maltoni; Alice Andalò; Martina Cavallucci; Maddalena Sansovini et al.
Source: check_circle
Crossref

Insights into an Autologous Dendritic Cells Vaccine for Glioblastoma: First Step Results from a Phase II Study (CombiG-Vax)

2023-12-28 | Preprint
Contributors: Laura Ridolfi; Lorena Gurrieri; Nada Riva; Jenny Bulgarelli; Francesco De Rosa; Massimo Guidoboni; Valentina Fausti; Nicoletta Ranallo; Sebastiano Calpona; Marcella Tazzari et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin

Cancers
2023-02 | Journal article | Author
Contributors: Valentina Fausti; Alessandro De Vita; Silvia Vanni; Virginia Ghini; Lorena Gurrieri; Nada Riva; Roberto Casadei; Marco Maraldi; Giorgio Ercolani; Davide Cavaliere et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Cancer patient perspective in the arena of COVID-19 pandemic

Psycho-Oncology
2022 | Journal article
EID:

2-s2.0-85112829800

Part of ISSN: 10991611 10579249
Contributors: Ballatore, Z.; Merloni, F.; Ranallo, N.; Bastianelli, L.; Vitarelli, F.; Cantini, L.; Ricci, G.; Ferretti, B.; Alessandroni, P.; Del Prete, M. et al.
Source: Self-asserted source
Nicoletta Ranallo via Scopus - Elsevier

Delta-like ligand 3 (DLL3): an attractive actionable target in tumors with neuroendocrine origin

Expert Review of Anticancer Therapy
2022 | Journal article
EID:

2-s2.0-85132207309

Part of ISSN: 17448328 14737140
Contributors: Ranallo, N.; Bocchini, M.; Menis, J.; Pilotto, S.; Severi, S.; Liverani, C.; Bongiovanni, A.
Source: Self-asserted source
Nicoletta Ranallo via Scopus - Elsevier

177Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials

Cancers
2022-12-07 | Journal article
Contributors: Alberto Bongiovanni; Silvia Nicolini; Toni Ibrahim; Flavia Foca; Maddalena Sansovini; Arianna Di Paolo; Ilaria Grassi; Chiara Liverani; Chiara Calabrese; Nicoletta Ranallo et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis

Cancers
2022-06-30 | Journal article
Contributors: Nicoletta Ranallo; Andrea Prochoswski Iamurri; Flavia Foca; Chiara Liverani; Alessandro De Vita; Laura Mercatali; Chiara Calabrese; Chiara Spadazzi; Carlo Fabbri; Davide Cavaliere et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review

Exploration of Targeted Anti-tumor Therapy
2021 | Journal article
EID:

2-s2.0-85118549809

Part of ISSN: 26923114
Contributors: Cognigni, V.; Ranallo, N.; Tronconi, F.; Morgese, F.; Berardi, R.
Source: Self-asserted source
Nicoletta Ranallo via Scopus - Elsevier

The gustave roussy immune (Grim)-score variation is an early-on-treatment biomarker of outcome in advanced non-small cell lung cancer (nsclc) patients treated with first-line pembrolizumab

Journal of Clinical Medicine
2021 | Journal article
EID:

2-s2.0-85105800790

Part of ISSN: 20770383
Contributors: Lenci, E.; Cantini, L.; Pecci, F.; Cognigni, V.; Agostinelli, V.; Mentrasti, G.; Lupi, A.; Ranallo, N.; Paoloni, F.; Rinaldi, S. et al.
Source: Self-asserted source
Nicoletta Ranallo via Scopus - Elsevier

Theragnostic in neuroendocrine tumors

Quarterly Journal of Nuclear Medicine and Molecular Imaging
2021 | Journal article
EID:

2-s2.0-85124436014

Part of ISSN: 18271936 18244785
Contributors: Marini, I.; Sansovini, M.; Bongiovanni, A.; Nicolini, S.; Grassi, I.; Ranallo, N.; Monti, M.; Iorio, V.D.I.; Germanò, L.; Caroli, P. et al.
Source: Self-asserted source
Nicoletta Ranallo via Scopus - Elsevier

Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic

JCO Global Oncology
2020 | Journal article
EID:

2-s2.0-85087683789

Part of ISSN: 26878941
Contributors: Ballatore, Z.; Bastianelli, L.; Merloni, F.; Ranallo, N.; Cantini, L.; Marcantognini, G.; Berardi, R.
Source: Self-asserted source
Nicoletta Ranallo via Scopus - Elsevier

Tailored therapy in patients treated with fluoropyrimidines: focus on the role of dihydropyrimidine dehydrogenase

Cancer Drug Resistance
2019 | Journal article
EID:

2-s2.0-85107408559

Part of ISSN: 2578532X
Contributors: Merloni, F.; Ranallo, N.; Scortichini, L.; Giampieri, R.; Berardi, R.
Source: Self-asserted source
Nicoletta Ranallo via Scopus - Elsevier